The Pill vs The Superbug

The Slow Pandemic Nobody Discusses

Antimicrobial resistance is the crisis without a villain, without a news cycle, and without a ribbon. In 2019, drug-resistant bacteria directly killed 1.27 million people and were associated with 4.95 million deaths worldwide. The September 2024 update from the Lancet projects 1.91 million direct AMR deaths per year by 2050—a cumulative 39 million over 25 years. For context, HIV/AIDS has killed approximately 40 million people in four decades.

The WHO calls AMR one of the top ten global public health threats. Third-generation cephalosporin-resistant E. coli is found in 42% of samples across 76 countries. MRSA prevalence stands at 35% globally. The economic damage: $1 trillion in additional healthcare costs and $1–3.4 trillion in annual GDP losses from 2030 onward.

Antimicrobial resistance is a slow-moving pandemic. Unlike COVID-19, it won’t generate a crisis response until millions have already died. — Dame Sally Davies, UK Special Envoy on AMR

The Pharma Exodus

Between 2016 and 2018, Novartis, AstraZeneca, and Sanofi all exited or drastically reduced antibiotic research. In 2019, Achaogen filed for bankruptcy—one year after the FDA approved its antibiotic plazomicin. Melinta Therapeutics followed into bankruptcy the same year.

The math is brutal. A new antibiotic earns on average $46 million per year in its first five years. Semaglutide—sold as Ozempic and Wegovy—generates approximately $25–30 billion per year for Novo Nordisk. A single weight-loss drug earns in roughly eight hours what a life-saving antibiotic earns in a year.

The 30–50% Problem

Between 30% and 50% of all antibiotic prescriptions globally are unnecessary—prescribed for viral infections where antibiotics have zero effect. In low- and middle-income countries, the rate may reach 40–60%. Pediatric populations are disproportionately affected: children get more infections, visit doctors more often, and receive more prescriptions. Every unnecessary course breeds resistance.

A critical nuance from the 2024 Lancet data: AMR deaths in children under 5 have actually declined 50% since 1990—thanks to improved sanitation, vaccines, and water access. But AMR deaths in people over 70 have increased 80%. The AMR crisis is shifting from a pediatric emergency to a geriatric one. This doesn’t eliminate the pediatric angle, but it complicates the simple narrative.

The Correlation Nobody Discusses

The Netherlands: sex education from age 4, contraception covered by insurance for women under 21, abortion rate of 8.7 per 1,000 women (among Europe’s lowest), teen pregnancy rate of 3.8 per 1,000, antibiotic consumption of roughly 10 DDD per 1,000 inhabitants per day (among EU’s lowest), and antimicrobial resistance rates among the lowest on the continent.

Romania: abortion and contraception banned under Decree 770 from 1966 to 1989, 10,000 women dead from illegal abortions, 100,000+ children warehoused in orphanages, and today one of Europe’s highest antibiotic consumption rates at 30+ DDD per 1,000 inhabitants per day, with AMR rates among the EU’s highest.

The correlation is real. But the mechanism is not “pill prevents superbugs.” The mechanism is institutional. The same governance qualities—evidence-based policy, educational investment, healthcare infrastructure, respect for individual autonomy—produce both good reproductive health outcomes and good antibiotic stewardship. The same governance failures—religious interference in healthcare, weak institutions, contempt for evidence—produce both restricted contraception and antibiotic misuse.

The world cannot be understood without numbers. And it cannot be understood with numbers alone. — Hans Rosling, Factfulness (2018)

The Arithmetic of “Pro-Life”

Abortion rates are similar in countries where abortion is restricted and those where it is broadly legal. Excluding China and India, rates are actually higher in restrictive countries. In restrictive countries, the proportion of unintended pregnancies ending in abortion rose from 36% (1990–1994) to 50% (2015–2019). Banning abortion doesn’t reduce abortion. It makes it lethal.

Approximately 39,000 women die each year from unsafe abortion. In Latin America and Africa, three out of four abortions are unsafe. In Africa, nearly half are performed under the “least safe conditions”—untrained providers, dangerous methods. Safe abortion has a mortality rate below 1 per 100,000. Unsafe abortion: above 200 per 100,000.

The most effective policy for reducing abortion is not banning it. It is providing comprehensive sex education and universal contraception access. The Netherlands demonstrates this with mathematical precision.

The Switch

Countries that trust women with their own bodies also trust science with their medicine. Countries that legislate morality into healthcare produce more abortions (just unsafe ones), more maternal deaths, and more antibiotic resistance.

This is not a claim that contraception directly prevents superbugs. It is an observation that the institutional capacity to deliver evidence-based reproductive healthcare is the same institutional capacity needed to deliver rational antibiotic policy. You cannot build one without the other. And the countries that refuse to build either are paying with bodies—women’s bodies and everybody’s bodies.